Sector Chart Madrigal Pharmaceuticals, Inc.
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 516.56 USD | +0.65% |
|
-2.81% | -11.30% |
| 09-24 | Analyst recommendations: Dropbox, Etsy, Meta Platforms, Okta, Rollins… |  |
| 09-23 | Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 11.93B | - | ||||
| 72.26B | |||||
| 60.24B | |||||
| 27.73B | |||||
| 25.73B | - | ||||
| 24.75B | - |
Select your edition
All financial news and data tailored to specific country editions
